BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8681411)

  • 21. Novel conformationally restricted triazole derivatives with potent antifungal activity.
    Wang W; Wang S; Liu Y; Dong G; Cao Y; Miao Z; Yao J; Zhang W; Sheng C
    Eur J Med Chem; 2010 Dec; 45(12):6020-6. PubMed ID: 20950895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optically active antifungal azoles. XII. Synthesis and antifungal activity of the water-soluble prodrugs of 1-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-[4-(1H-1-tetrazolyl)phenyl]-2-imidazolidinone.
    Ichikawa T; Kitazaki T; Matsushita Y; Yamada M; Hayashi R; Yamaguchi M; Kiyota Y; Okonogi K; Itoh K
    Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1102-9. PubMed ID: 11558595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo activities of syn2836, syn2869, syn2903, and syn2921: new series of triazole antifungal agents.
    Salama SM; Atwal H; Gandhi A; Simon J; Poglod M; Montaseri H; Khan JK; Furukawa T; Saito H; Nishida K; Higashitani F; Uji T; Unemi N; Daneshtalab M; Micetich RG
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2420-6. PubMed ID: 11502508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optically active antifungal azoles. VI. Synthesis and antifungal activity of N-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazo l-1- yl)propyl]-N'-(4-substituted phenyl)-3(2H,4H)-1,2,4-triazolones and 5(1H,4H)-tetrazolones.
    Kitazaki T; Tamura N; Tasaka A; Matsushita Y; Hayashi R; Okonogi K; Itoh K
    Chem Pharm Bull (Tokyo); 1996 Feb; 44(2):314-27. PubMed ID: 8998838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and antifungal activity of novel conformationally restricted triazole derivatives.
    Wang W; Sheng C; Che X; Ji H; Miao Z; Yao J; Zhang WN
    Arch Pharm (Weinheim); 2009 Dec; 342(12):732-9. PubMed ID: 19899102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optically active antifungal azoles. IV. Synthesis and antifungal activity of (2R,3R)-3-azolyl-2-(substituted phenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanols.
    Tasaka A; Tamura N; Matsushita Y; Kitazaki T; Hayashi R; Okonogi K; Itoh K
    Chem Pharm Bull (Tokyo); 1995 Mar; 43(3):432-40. PubMed ID: 7774026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of NND-502, a novel imidazole antimycotic agent, in experimental models of Candida albicans and Aspergillus fumigatus infections.
    Niwano Y; Kuzuhara N; Goto Y; Munechika Y; Kodama H; Kanai K; Yoshida M; Miyazaki T; Yamaguchi H
    Int J Antimicrob Agents; 1999 Aug; 12(3):221-8. PubMed ID: 10461840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antifungal activity of novel thiazole-containing triazole antifungals. II. Optically active ER-30346 and its derivatives.
    Tsuruoka A; Kaku Y; Kakinuma H; Tsukada I; Yanagisawa M; Nara K; Naito T
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):623-30. PubMed ID: 9579038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatal Aspergillus fumigatus and Candida glabrata infections with posaconazole prophylaxis after stem cell transplantation.
    Ustun C; DeRemer DL; Steele JC; Forseen C; Fisher JF; Jillella AP
    Int J Antimicrob Agents; 2008 Oct; 32(4):365-6. PubMed ID: 18572390
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis of novel 3-(1-(1-substituted piperidin-4-yl)-1H-1,2,3-triazol-4-yl)-1,2,4-oxadiazol-5(4H)-one as antifungal agents.
    Sangshetti JN; Nagawade RR; Shinde DB
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3564-7. PubMed ID: 19464891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and in-vitro antifungal activity of 6-substituted-phenyl-2- {[(4'-substituted phenyl-5'-thioxo)-1,2,4-triazol-3-yl]-methyl}-2,3,4,5-tetrahydropyridazin-3-one derivatives.
    Siddiqui AA; Ahamad SR; Mira MS; Hussain SA; Raish M; Kaur R
    Acta Pol Pharm; 2008; 65(2):223-8. PubMed ID: 18666429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient regioselective three-component domino synthesis of 3-(1,2,4-Triazol-5-yl)-1,3-thiazolidin-4-ones as potent antifungal and antituberculosis agents.
    El Bialy SA; Nagy MM; Abdel-Rahman HM
    Arch Pharm (Weinheim); 2011 Dec; 344(12):821-9. PubMed ID: 21932255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synthesis and antifungal activities of 1-(1-substitutedphenyl)-2-(1H-1,2,4-triazol or benztriazol-1-yl)-O-(substitutedbenzyl) ethanoximes].
    Cheng Q; Li CR; Xing YF
    Yao Xue Xue Bao; 1997; 32(1):49-55. PubMed ID: 11243218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optically active antifungal azoles. I. Synthesis and antifungal activity of (2R,3R)-2-(2,4-difluorophenyl)-3-mercapto-1-(1H-1,2,4-triazol-1-yl)-2-b utanol and its stereoisomers.
    Tasaka A; Tamura N; Matsushita Y; Teranishi K; Hayashi R; Okonogi K; Itoh K
    Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1035-42. PubMed ID: 8370103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans.
    Takahata S; Okutomi T; Ohtsuka K; Hoshiko S; Uchida K; Yamaguchi H
    Med Mycol; 2005 May; 43(3):227-33. PubMed ID: 16010849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optically active antifungal azoles. VII. Synthesis and antifungal activity of stereoisomers of 2-[(1R,2R)-2-(2, 4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl) propyl]-4-[4-(2,2,3,3-tetrafluoropropoxy)phenyl]-3(2H,4H)-1,2,4-triazo lone (TAK-187).
    Tasaka A; Kitazaki T; Tsuchimori N; Matsushita Y; Hayashi R; Okonogi K; Itoh K
    Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):321-6. PubMed ID: 9118446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
    Bartroli J; Turmo E; Algueró M; Boncompte E; Vericat ML; Conte L; Ramis J; Merlos M; García-Rafanell J; Forn J
    J Med Chem; 1998 May; 41(11):1869-82. PubMed ID: 9599237
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents.
    Jiang Y; Zhang J; Cao Y; Chai X; Zou Y; Wu Q; Zhang D; Jiang Y; Sun Q
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4471-5. PubMed ID: 21737273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, In Vitro Biological Evaluation, and Molecular Docking of New Triazoles as Potent Antifungal Agents.
    Li X; Liu C; Tang S; Wu Q; Hu H; Zhao Q; Zou Y
    Arch Pharm (Weinheim); 2016 Jan; 349(1):42-9. PubMed ID: 26641629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New antifungal 1,2,4-triazoles with difluoro(substituted sulfonyl)methyl moiety.
    Eto H; Kaneko Y; Takeda S; Tokizawa M; Sato S; Yoshida K; Namiki S; Ogawa M; Maebashi K; Ishida K; Matsumoto M; Asaoka T
    Chem Pharm Bull (Tokyo); 2001 Feb; 49(2):173-82. PubMed ID: 11217105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.